After an ACL tear: Research opens door to new treatments to improve recovery for athletes

U-M Health System findings identify new drug target to prevent muscle weakness and loss after common and serious knee injury among athletes

2013-06-13

(Press-News.org) ANN ARBOR, Mich. — Striking the likes of Chicago Bulls' Derrick Rose, L.A. Lakers' Kobe Bryant and Detroit Tigers' Victor Martinez, tears in the anterior cruciate ligament (ACL) are one of the most rampant and serious knee injuries among athletes.

Now, researchers from the University of Michigan Health System have identified a new drug target that may prevent one of the most dreaded consequences of an ACL tear –the weakening or loss of muscle tissue (muscle atrophy) that can be a career-killer in sports and ultimately develop into osteoarthritis.

A hormone called myostatin that blocks muscle growth appears to play a key role in causing muscle damage after ACL tears, according to a study that appears in the American Journal of Sports Medicine. The findings pave the way for potential treatment preventing muscle loss after an ACL tear and consequent knee replacement, which affects more than 250,000 people a year in the U.S.

"We've had several advances in technology to improve the recovery process for an ACL tear, but most patients still experience 30-40 percent muscle weakness – and that weakness largely limits the ability to return to the same level of sports," says lead author and athletic trainer Christopher L. Mendias, Ph.D., A.T.C, assistant professor of Orthopaedic Surgery and Molecular & Integrative Physiology at the U-M Medical School.

"This is the first study in humans to open the door to a potential therapy to prevent muscle atrophy. We see this as an important step in restoring athletic and functional abilities in the short term, and in preventing osteoarthritis in the long term."

Often dubbed an athlete's worst nightmare, ACL tears usually require surgical repairs and months of intense rehabilitation that force long breaks from playing any sports.

Myostatin has shown promise as a potential drug target for treating other conditions such as muscular dystrophy and cancer, and blocking the protein has led to increased muscle mass and strength.

"In the sports world, there's great concern about the short-term and long-term affect of an ACL tear on not only an athlete's physical skills and ability to return to play, but also the longevity and health of the knee joint," says senior author Asheesh Bedi, M.D., assistant professor in orthopedic surgery.

"This is the first study to look into the biology of muscle tissue involved in an ACL tear and to show how Myostatin affects the muscle damage we see following surgery. We need further studies to examine how these findings may aid in better recoveries following a common and often detrimental type of knee injury for athletes."

INFORMATION:

Additional authors: Evan B. Lynch, B.S.E.; Max E. Davis, B.A.; Elizabeth R. Sibilsky Enselman, ME.d.,A.T.C.; Julie A. Harning; Paul D. DeWolf, B.S.; Tarek A. Makki, B.S.

Funding: National Institute of Arthritis and Musculoskeletal and Skin Diseases grant number AR058920

Disclosures: None

Reference: "Changes in Circulating Biomarkers of Muscle Atrophy, Inflammation and Cartilage Turnover in Patients Undergoing Anterior Cruciate Ligament Reconstruction and Rehabilitation," American Journal of Sports Medicine, DOI:10.1177/0363546513490651.

ELSE PRESS RELEASES FROM THIS DATE:

Researchers gain new molecular-level understanding of the brain's recovery after stroke

2013-06-13

DETROIT – A specific MicroRNA, a short set of RNA (ribonuclease) sequences, naturally packaged into minute (50 nanometers) lipid containers called exosomes, are released by stem cells after a stroke and contribute to better neurological recovery according to a new animal study by Henry Ford Hospital researchers. The important role of a specific microRNA transferred from stem cells to brain cells via the exosomes to enhance functional recovery after a stroke was shown in lab rats. This study provides fundamental new insight into how stem cells affect injured tissue and ...

Light-carved 'nano-volcanoes' hold promise for drug delivery

2013-06-13

Researchers from North Carolina State University have developed a method for creating "nano-volcanoes" by shining various colors of light through a nanoscale "crystal ball" made of a synthetic polymer. These nano-volcanoes can store precise amounts of other materials and hold promise for new drug-delivery technologies. The researchers create the nano-volcanoes by placing spherical, transparent polymer nanoparticles directly onto the flat surface of a thin film. They then shine ultraviolet light through the transparent sphere, which scatters the light and creates a pattern ...

DNA brings materials to life

2013-06-13

A colloid is a substance spread out evenly inside another substance. Everyday examples include milk, styrofoam, hair sprays, paints, shaving foam, gels and even dust, mud and fog. One of the most interesting properties of colloids is their ability to self-assemble – to aggregate spontaneously into well-defined structures, driven by nothing but local interactions between the colloid's particles. Self-assembly has been of major interest in industry, since controlling it would open up a whole host of new technologies, such as smart drug-delivery patches or novel paints that ...

DNA sequencing uncovers secrets of white cliffs of Dover

2013-06-13

The University of Exeter recently contributed to a major international project to sequence the genome of Emiliania huxleyi, the microscopic plankton species whose chalky skeletons form the iconic white cliffs of Dover. The results of the project are published this week in the journal Nature. Emiliania huxleyi is one of the most abundant marine phytoplankton species and is a key player in the process of CO2 exchange between the atmosphere and the ocean. In some marine systems 20% of the total carbon is fixed by E. huxleyi. This microscopic alga has influenced the global ...

UF study finds brain-imaging technique can help diagnose movement disorders

2013-06-13

GAINESVILLE, Fla. — A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson's disease. Utilizing the diffusion tensor imaging technique, as it is known, could allow clinicians to assess people earlier, leading to improved treatment interventions and therapies for patients. The three-year study looked at 72 patients, each with a clinically defined movement disorder diagnosis. Using a technique called diffusion tensor imaging, the researchers ...

Gene offers an athlete's heart without the exercise

2013-06-13

Researchers at Case Western Reserve University have found that a single gene poses a double threat to disease: Not only does it inhibit the growth and spread of breast tumors, but it also makes hearts healthier. In 2012, medical school researchers discovered the suppressive effects of the gene HEXIM1 on breast cancer in mouse models. Now they have demonstrated that it also enhances the number and density of blood vessels in the heart – a sure sign of cardiac fitness. Scientists re-expressed the HEXIM1 gene in the adult mouse heart and found that the hearts grew heavier ...

Study points to role of nervous system in arthritis

2013-06-13

Arthritis is a debilitating disorder affecting one in 10 Canadians, with pain caused by inflammation and damage to joints. Yet the condition is poorly managed in most patients, since adequate treatments are lacking – and the therapies that do exist to ease arthritis pain often cause serious side effects, particularly when used long-term. Any hope for developing more-effective treatments for arthritis relies on understanding the processes driving this condition. A new study in the Journal of Neuroscience by researchers at McGill University adds to a growing body of ...

A peptide to protect brain function

2013-06-13

A structure called "the microtubule network" is a crucial part of our nervous system. It acts as a transportation system within nerve cells, carrying essential proteins and enabling cell-to-cell communications. But in neurodegenerative diseases like Alzheimer's, ALS, and Parkinson's, this network breaks down, hindering motor abilities and cognitive function. Now Prof. Illana Gozes of Tel Aviv University's Sackler Faculty of Medicine has developed a new peptide in her lab, called NAP or Davunetide, that has the capacity to both protect and restore microtubule function. ...

Helping to restore balance after inner ear disorder

2013-06-13

Many disorders of the inner hear which affect both hearing and balance can be hugely debilitating and are currently largely incurable. Cochlear implants have been used for many years to replace lost hearing resulting from inner ear damage. However, to date, there has not been an analogous treatment for balance disorders resulting from inner ear disease. One potential new treatment is an implantable vestibular prosthesis which would directly activate the vestibular nerve by electrical stimulation. This prosthetic treatment is tested in a new study by Christopher Phillips ...

US forest management policy must evolve to meet bioenergy targets

2013-06-13

CHAMPAIGN, Ill. — In order to keep pace with the burgeoning demand for renewable energy, forest management policy in the U.S. must change to address environmental sustainability issues, according to an article by a University of Illinois expert in bioenergy law. Unless the forestry sector can tailor sustainable forest management policies specifically to forest-to-energy feedstocks, its role in helping the country broaden its energy portfolio – and by extension, meeting ambitious bioenergy targets – may be limited in large part because of uncertainty about whether existing ...

LAST 30 PRESS RELEASES:

SNU researchers develop world’s first technology to observe atomic structural changes of nanoparticles in 3D

SNU researchers develop a new synthesis technology of single crystal 2D semiconductors, “Hypotaxy,” to enhance the commercialization of next-generation 2D semiconductors